Lates News
Chengdu Shifeng Biotechnology: Its wholly-owned subsidiary Anhui Shifenglongkema Biopharmaceutical Co., Ltd. recently received the "Notice of Termination of Drug Registration Application" issued by the National Medical Products Administration, approving Shifenglongkema to withdraw the registration application for children's quadrivalent split influenza virus subunit vaccine and split influenza virus subunit vaccine.
Latest

